兔抗RGS22多克隆抗體

Background:

RGS22 (regulator of G-protein signaling 22), also known as FLJ75004, PRTD-NY2, FLJ40080, MGC102908 or DKFZp434I092, is a novel 1264 amino acid regulator of G-protein signaling specific to to testis. RGS22 inhibits signal transduction and contains two isoforms as a result of alternative splicing. RGS22 is found in spermatogenic cells and Leydig cells, and may be involved in the translocation of GNA13 from the cytoplasm to the nucleus during spermiogenesis. RGS22 contains two RGS domains: RGS1 and RGS2, and the gene encoding RGS22 maps to human chromosome 8q22.2.

Applications:

ELISA, WB, IHC

Name of antibody:

RGS22

Immunogen:

Fusion protein of human RGS22

Full name:

regulator of G-protein signaling 22

Synonyms：

CT145; PRTD-NY2

SwissProt:

Q8NE09

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human cervical cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

147 kDa

WB Positive control:

Hela and hepg2 cells

WB Recommended dilution:

500-2000